Data as of Sep 22
| -0.10 / -0.98%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 29.00 and a low estimate of 18.00. The median estimate represents a +87.75% increase from the last price of 10.12.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.